Real-life study of the effectiveness of a high calorie and high protein formula in the maintenance and improvement of nutritional state in patients with an indication of long-term enteral nutrition


Por: Pomar M, Carrera P, Pinera M, Orenes A, Romero L, Hernandez N, Usieto M, Mas F, Beneitez M, Viveros M, Aguilera C, Alcolea J

Publicada: 1 ene 2021
Resumen:
The selection of the most appropriate formula in long-term home enteral nutrition is a controversial issue. Our objective was to study a high protein hypercaloric enteral nutrition formula in patients with long-term feeding (180 days). Methods: Prospective observational multicenter real-life study with high-protein hypercaloric formula (2 kcal/ml and 20% protein). General, anthropometric, analytical and quality of life data were collected by visual analog scale of the European Quality of Life-5 Dimensions at the beginning, 60, 120 and 180 days. Gastrointestinal tolerance was assessed with a visual analog scale and Bristol Stool Scale and the risk of malnutrition was assessed using NRS-2002. Results: 51 patients (88.2% men, mean age 62.0 years), with oncological diseases in 72.5%. No differences in anthropometric data were observed, although the percentage of patients at risk of malnutrition according to NRS 2002 was reduced from 75% to 8.3% (p < 0.0001). No differences were observed in albumin, prealbumin, transferrin, lymphocytes or hematocrit. The quality of life improved from 3.84 (1.27) to 5.37 (1.12) on the visual analog scale (p < 0.0001). A reduction in gastrointestinal symptoms was observed throughout the period of enteral nutrition. Both the number and percentage of stools considered normal according to the Bristol scale remained stable. Conclusion: Our study supports that the use of high-protein hypercaloric formulas during a 6-month nutritional treatment allows an adequate nutritional evolution without risk of dehydration and with a good tolerance, even improvement of gastrointestinal symptoms, and can contribute to an improvement in the quality of lifetime. (C) 2020 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.

Filiaciones:
Pomar M:
 Hosp Univ Leon, Endocrinol & Nutr, Leon, Spain

Carrera P:
 Hosp Prov Castellon, Castellon de La Plana, Spain

Pinera M:
 Ctr Gerontol Ablana, Asturias, Spain

Orenes A:
 Hosp Virgen del Valle, Complejo Hosp Toledo, Toledo, Spain

Romero L:
 Hosp Basurto, Endocrinol & Nutr, Bilbao, Spain

Hernandez N:
 Hosp Basurto, Endocrinol & Nutr, Bilbao, Spain

Usieto M:
 Hosp Ejea de los Caballeros, Med Interna, Zaragoza, Spain

Mas F:
 Hosp Manacor, Endocrinol & Nutr, Palma De Mallorca, Spain

Beneitez M:
 Hosp San Juan Dios, Palma De Mallorca, Spain

Viveros M:
 Hosp Univ Getafe, Endocrinol & Nutr, Madrid, Spain

Aguilera C:
 Hosp Univ Getafe, Endocrinol & Nutr, Madrid, Spain

Alcolea J:
 Hosp Son Llatzer, Endocrinol & Nutr, Palma De Mallorca, Spain
ISSN: 25300180





Endocrinologia Diabetes y Nutricion
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, España
Tipo de documento: Article
Volumen: 68 Número: 1
Páginas: 11-16
WOS Id: 000605004600003
ID de PubMed: 32646843

MÉTRICAS